| 发明名称 |
PROTECTIVE EFFECT OF DMPC, DMPG, DMPC/DMPG, EGPG, LYSOPG AND LYSOPC AGAINST DRUGS THAT CAUSE CHANNELOPATHIES |
| 摘要 |
The present invention includes compositions and methods for preventing one or more cardiac channelopathies or conditions resulting from irregularities or alterations in cardiac patterns caused by an active agent or a drug in a human or animal subject comprising: an amount of a lysophosphatidyl compound adapted for oral administration effective to reduce or prevent one or more cardiac channelopathies or conditions resulting from irregularities or alterations in cardiac patterns caused by the active agent or drug. Such compositions may further comprise a monoglyceride, a free fatty acid or a combination of the foregoing, including, e.g., a eutectic mixture. |
| 申请公布号 |
US2015343063(A1) |
申请公布日期 |
2015.12.03 |
| 申请号 |
US201514729940 |
申请日期 |
2015.06.03 |
| 申请人 |
SignPath Pharma Inc. ;Avanti Polar Lipids, Inc. |
发明人 |
Helson Lawrence;Shopp George M.;Bouchard Annie;Majeed Muhammed;Burgess Stephen W.;Shaw Walter A. |
| 分类号 |
A61K47/24;A61K49/00;A61K45/06;G01N33/68;A61K31/506 |
主分类号 |
A61K47/24 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A composition for preventing or treating one or more cardiac channelopathies or conditions resulting from irregularities or alterations in cardiac patterns caused by one or more active agents, when the one or more active agents are administered to a human or animal subject, the composition comprising:
an amount of a lysophosphatidyl compound effective to reduce or prevent the one or more cardiac channelopathies or conditions resulting from irregularities or alterations in cardiac patterns caused by the active agent. |
| 地址 |
Quakertown PA US |
